Over the course of the week, we made 2 new trades — 1 buy and 1 sell.
Click here for the Momentum Ranking of week 04.
Welcome to this week’s portfolio update, where we’re still navigating a dynamic market enviroment. The momentum ranking strategy we use, inspired by Andreas Clenow’s book ‘Stocks on the Move’, helps us make more informed decisions by focusing on trends rather than being swayed by daily news like Greenland policies or tariff changes. Today, the S&P 500 has been above its 200-day moving average for 174 days, allowing us to stay invested. With only 2.1% held in cash, we’re nearly fully invested in our momentum-based strategy.
This week, we initiated a new position by purchasing Globus Medical (GMED), a company specializing in musculoskeletal solutions within the healthcare sector. We also made the decision to sell our stake in Medpace Holdings (MEDP), following the systematic rules set by our ranking strategy. We trimmed our position in Haemonetics (HAE), aligning with its recent performance.
Technology emerged as our top sector, often serving as the backbone for innovation and growth in an investment portfolio. This focus includes companies like Applied Materials (AMAT), a supplier of equipment used in semiconductor manufacturing. Our current top holdings are Warner Bros Discovery (WBD), Applied Materials (AMAT), and Globus Medical (GMED), each contributing uniquely to our portfolio. Among our stocks, Hecla Mining (HL) performed the best with a 26.32% gain, while Haemonetics (HAE) lagged slightly behind at -14.12%.
We’re satisfied with our rules-based momentum ranking approach, as it streamlines decision-making without needing to track everyday news. Feel free to share your thoughts or questions in the comments—I’m always eager to discuss strategies with fellow investors!
This week’s transactions:
-
Rebalanced / added:
- No positions were added to in this week!
-
Rebalanced / reduced:
Index Distribution:
The majority of our portfolio is currently made up of stocks from the S&P 400 sector.
Current portfolio allocation:
Right now, we’ve got a big chunk of our portfolio in the Technology sector.
Weekly sector distribution:
Current portfolio (@finviz):
| Symbol | Name | Index | Sector | MC | Dist to 52w High | pct |
|---|---|---|---|---|---|---|
| WBD | Warner Bros. Discovery Inc | S&P 500 | Communication Services | 70.37B | -5.35% | 0.079 |
| AMAT | Applied Materials Inc | S&P 500 | Technology | 252.95B | -3.63% | 0.072 |
| GMED | Globus Medical Inc | S&P 400 | Healthcare | 12.52B | -8.25% | 0.068 |
| TER | Teradyne, Inc | S&P 500 | Technology | 35.15B | -6.06% | 0.063 |
| ROIV | Roivant Sciences Ltd | S&P 400 | Healthcare | 15.77B | -5.19% | 0.06 |
| CIEN | CIENA Corp | S&P 400 | Technology | 34.12B | -7.25% | 0.05 |
| ALB | Albemarle Corp | S&P 500 | Basic Materials | 19.55B | -7.29% | 0.049 |
| FN | Fabrinet | S&P 400 | Technology | 17.70B | -7.02% | 0.048 |
| FIX | Comfort Systems USA, Inc | S&P 500 | Consumer Cyclical | 39.59B | -2.13% | 0.046 |
| WDC | Western Digital Corp | S&P 500 | Technology | 77.47B | -1.69% | 0.046 |
| MU | Micron Technology Inc | S&P 500 | Technology | 415.50B | 0.92% | 0.045 |
| INTC | Intel Corp | S&P 500 | Technology | 245.73B | -2.17% | 0.045 |
| CYTK | Cytokinetics Inc | S&P 400 | Healthcare | 7.65B | -11.88% | 0.044 |
| HL | Hecla Mining Co | S&P 400 | Consumer Cyclical | 18.02B | 1.17% | 0.041 |
| AA | Alcoa Corp | S&P 400 | Basic Materials | 15.67B | -9.61% | 0.04 |
| SATS | EchoStar Corp | S&P 400 | Communication Services | 35.43B | -6.94% | 0.036 |
| HAE | Haemonetics Corp | S&P 400 | Healthcare | 3.33B | -18.62% | 0.034 |
| COHR | Coherent Corp | S&P 400 | Technology | 30.78B | -7.14% | 0.031 |
| AMKR | AMKOR Technology Inc | S&P 400 | Technology | 11.94B | -10.87% | 0.031 |
| STX | Seagate Technology Holdings Plc | S&P 500 | Technology | 70.83B | -1.00% | 0.027 |
| LITE | Lumentum Holdings Inc | S&P 400 | Technology | 24.62B | -13.78% | 0.027 |
| cash | Cash | Cash | Cash | – | - | 0.021 |
As always, more trades next week!